Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 70 entries
Sorted by: Best Match Show Resources per page
Surgical treatment of clavicle fractures in the adolescent athlete.

Sports health

Fanter NJ, Kenny RM, Baker CL, Baker CL.
PMID: 25984259
Sports Health. 2015 Mar;7(2):137-41. doi: 10.1177/1941738114566381.

CONTEXT: Current literature has clearly shown that the indications for surgical treatment of clavicle fractures in adults are expanding. Although clavicle fractures in children and adolescents have traditionally been treated nonoperatively, surgical treatment of displaced clavicle fractures may be...

Cite
Fanter NJ, Kenny RM, Baker CL, et al. Surgical treatment of clavicle fractures in the adolescent athlete. Sports Health. 2015;7(2):137-41doi: 10.1177/1941738114566381.
Fanter, N. J., Kenny, R. M., Baker, C. L., & Baker, C. L. (2015). Surgical treatment of clavicle fractures in the adolescent athlete. Sports health, 7(2), 137-41. https://doi.org/10.1177/1941738114566381
Fanter, Nathan J, et al. "Surgical treatment of clavicle fractures in the adolescent athlete." Sports health vol. 7,2 (2015): 137-41. doi: https://doi.org/10.1177/1941738114566381
Fanter NJ, Kenny RM, Baker CL, Baker CL. Surgical treatment of clavicle fractures in the adolescent athlete. Sports Health. 2015 Mar;7(2):137-41. doi: 10.1177/1941738114566381. PMID: 25984259; PMCID: PMC4332647.
Copy Download .nbib Format: NLM
MyPlate myths debunked.

Journal of the Academy of Nutrition and Dietetics

Haven J, Maniscalco S, Bard S, Ciampo M.
PMID: 24731523
J Acad Nutr Diet. 2014 May;114(5):674-5. doi: 10.1016/j.jand.2014.03.006.

No abstract available.

Cite
Haven J, Maniscalco S, Bard S, et al. MyPlate myths debunked. J Acad Nutr Diet. 2014;114(5):674-5doi: 10.1016/j.jand.2014.03.006.
Haven, J., Maniscalco, S., Bard, S., & Ciampo, M. (2014). MyPlate myths debunked. Journal of the Academy of Nutrition and Dietetics, 114(5), 674-5. https://doi.org/10.1016/j.jand.2014.03.006
Haven, Jackie, et al. "MyPlate myths debunked." Journal of the Academy of Nutrition and Dietetics vol. 114,5 (2014): 674-5. doi: https://doi.org/10.1016/j.jand.2014.03.006
Haven J, Maniscalco S, Bard S, Ciampo M. MyPlate myths debunked. J Acad Nutr Diet. 2014 May;114(5):674-5. doi: 10.1016/j.jand.2014.03.006. PMID: 24731523.
Copy Download .nbib Format: NLM
The first reported case of trastuzumab induced interstitial lung disease associated with anti-neutrophil cytoplasmic antibody vasculitis - A case report and a prospective cohort study on the usefulness of neutrophil derived biomarkers in monitoring vasculitis disease activity during follow-up.

Breast (Edinburgh, Scotland)

Chang CH, Jung CJ, Huang YM, Chiao L, Chang YL, Hsieh SC, Lin CH, Kuo YM.
PMID: 34894465
Breast. 2021 Nov 29;61:35-42. doi: 10.1016/j.breast.2021.11.016. Epub 2021 Nov 29.

Targeted therapies against human epidermal growth factor receptor 2 (HER2) are associated with increased interstitial lung disease (ILD). Trastuzumab, lapatinib, pertuzumab, and trastuzumab emtansine have markedly extended HER2 breast cancer survival but current knowledge on how these HER2-targeted agents...

Cite
Chang CH, Jung CJ, Huang YM, et al. The first reported case of trastuzumab induced interstitial lung disease associated with anti-neutrophil cytoplasmic antibody vasculitis - A case report and a prospective cohort study on the usefulness of neutrophil derived biomarkers in monitoring vasculitis disease activity during follow-up. Breast. 2021;61:35-42doi: 10.1016/j.breast.2021.11.016.
Chang, C. H., Jung, C. J., Huang, Y. M., Chiao, L., Chang, Y. L., Hsieh, S. C., Lin, C. H., & Kuo, Y. M. (2021). The first reported case of trastuzumab induced interstitial lung disease associated with anti-neutrophil cytoplasmic antibody vasculitis - A case report and a prospective cohort study on the usefulness of neutrophil derived biomarkers in monitoring vasculitis disease activity during follow-up. Breast (Edinburgh, Scotland), 6135-42. https://doi.org/10.1016/j.breast.2021.11.016
Chang, Chen-Han, et al. "The first reported case of trastuzumab induced interstitial lung disease associated with anti-neutrophil cytoplasmic antibody vasculitis - A case report and a prospective cohort study on the usefulness of neutrophil derived biomarkers in monitoring vasculitis disease activity during follow-up." Breast (Edinburgh, Scotland) vol. 61 (2021): 35-42. doi: https://doi.org/10.1016/j.breast.2021.11.016
Chang CH, Jung CJ, Huang YM, Chiao L, Chang YL, Hsieh SC, Lin CH, Kuo YM. The first reported case of trastuzumab induced interstitial lung disease associated with anti-neutrophil cytoplasmic antibody vasculitis - A case report and a prospective cohort study on the usefulness of neutrophil derived biomarkers in monitoring vasculitis disease activity during follow-up. Breast. 2021 Nov 29;61:35-42. doi: 10.1016/j.breast.2021.11.016. Epub 2021 Nov 29. PMID: 34894465; PMCID: PMC8669110.
Copy Download .nbib Format: NLM
The first reported case of trastuzumab induced interstitial lung disease associated with anti-neutrophil cytoplasmic antibody vasculitis - A case report and a prospective cohort study on the usefulness of neutrophil derived biomarkers in monitoring vasculitis disease activity during follow-up.

Breast (Edinburgh, Scotland)

Chang CH, Jung CJ, Huang YM, Chiao L, Chang YL, Hsieh SC, Lin CH, Kuo YM.
PMID: 34894465
Breast. 2021 Nov 29;61:35-42. doi: 10.1016/j.breast.2021.11.016. Epub 2021 Nov 29.

Targeted therapies against human epidermal growth factor receptor 2 (HER2) are associated with increased interstitial lung disease (ILD). Trastuzumab, lapatinib, pertuzumab, and trastuzumab emtansine have markedly extended HER2 breast cancer survival but current knowledge on how these HER2-targeted agents...

Cite
Chang CH, Jung CJ, Huang YM, et al. The first reported case of trastuzumab induced interstitial lung disease associated with anti-neutrophil cytoplasmic antibody vasculitis - A case report and a prospective cohort study on the usefulness of neutrophil derived biomarkers in monitoring vasculitis disease activity during follow-up. Breast. 2021;61:35-42doi: 10.1016/j.breast.2021.11.016.
Chang, C. H., Jung, C. J., Huang, Y. M., Chiao, L., Chang, Y. L., Hsieh, S. C., Lin, C. H., & Kuo, Y. M. (2021). The first reported case of trastuzumab induced interstitial lung disease associated with anti-neutrophil cytoplasmic antibody vasculitis - A case report and a prospective cohort study on the usefulness of neutrophil derived biomarkers in monitoring vasculitis disease activity during follow-up. Breast (Edinburgh, Scotland), 6135-42. https://doi.org/10.1016/j.breast.2021.11.016
Chang, Chen-Han, et al. "The first reported case of trastuzumab induced interstitial lung disease associated with anti-neutrophil cytoplasmic antibody vasculitis - A case report and a prospective cohort study on the usefulness of neutrophil derived biomarkers in monitoring vasculitis disease activity during follow-up." Breast (Edinburgh, Scotland) vol. 61 (2021): 35-42. doi: https://doi.org/10.1016/j.breast.2021.11.016
Chang CH, Jung CJ, Huang YM, Chiao L, Chang YL, Hsieh SC, Lin CH, Kuo YM. The first reported case of trastuzumab induced interstitial lung disease associated with anti-neutrophil cytoplasmic antibody vasculitis - A case report and a prospective cohort study on the usefulness of neutrophil derived biomarkers in monitoring vasculitis disease activity during follow-up. Breast. 2021 Nov 29;61:35-42. doi: 10.1016/j.breast.2021.11.016. Epub 2021 Nov 29. PMID: 34894465.
Copy Download .nbib Format: NLM
The Oxford Classic Links Epithelial-to-Mesenchymal Transition to Immunosuppression in Poor Prognosis Ovarian Cancers.

Clinical cancer research : an official journal of the American Association for Cancer Research

Hu Z, Cunnea P, Zhong Z, Lu H, Osagie OI, Campo L, Artibani M, Nixon K, Ploski J, Santana Gonzalez L, Alsaadi A, Wietek N, Damato S, Dhar S, Blagden SP, Yau C, Hester J, Albukhari A, Aboagye EO, Fotopoulou C, Ahmed A.
PMID: 33446563
Clin Cancer Res. 2021 Mar 01;27(5):1570-1579. doi: 10.1158/1078-0432.CCR-20-2782. Epub 2021 Jan 14.

PURPOSE: Using RNA sequencing, we recently developed the 52-gene-based Oxford classifier of carcinoma of the ovary (Oxford Classic, OxC) for molecular stratification of serous ovarian cancers (SOCs) based on the molecular profiles of their cell of origin in the...

Cite
Hu Z, Cunnea P, Zhong Z, et al. The Oxford Classic Links Epithelial-to-Mesenchymal Transition to Immunosuppression in Poor Prognosis Ovarian Cancers. Clin Cancer Res. 2021;27(5):1570-1579doi: 10.1158/1078-0432.CCR-20-2782.
Hu, Z., Cunnea, P., Zhong, Z., Lu, H., Osagie, O. I., Campo, L., Artibani, M., Nixon, K., Ploski, J., Santana Gonzalez, L., Alsaadi, A., Wietek, N., Damato, S., Dhar, S., Blagden, S. P., Yau, C., Hester, J., Albukhari, A., Aboagye, E. O., Fotopoulou, C., & Ahmed, A. (2021). The Oxford Classic Links Epithelial-to-Mesenchymal Transition to Immunosuppression in Poor Prognosis Ovarian Cancers. Clinical cancer research : an official journal of the American Association for Cancer Research, 27(5), 1570-1579. https://doi.org/10.1158/1078-0432.CCR-20-2782
Hu, Zhiyuan, et al. "The Oxford Classic Links Epithelial-to-Mesenchymal Transition to Immunosuppression in Poor Prognosis Ovarian Cancers." Clinical cancer research : an official journal of the American Association for Cancer Research vol. 27,5 (2021): 1570-1579. doi: https://doi.org/10.1158/1078-0432.CCR-20-2782
Hu Z, Cunnea P, Zhong Z, Lu H, Osagie OI, Campo L, Artibani M, Nixon K, Ploski J, Santana Gonzalez L, Alsaadi A, Wietek N, Damato S, Dhar S, Blagden SP, Yau C, Hester J, Albukhari A, Aboagye EO, Fotopoulou C, Ahmed A. The Oxford Classic Links Epithelial-to-Mesenchymal Transition to Immunosuppression in Poor Prognosis Ovarian Cancers. Clin Cancer Res. 2021 Mar 01;27(5):1570-1579. doi: 10.1158/1078-0432.CCR-20-2782. Epub 2021 Jan 14. PMID: 33446563.
Copy Download .nbib Format: NLM
Structural Polymorphism of Resorcinarene Assemblies.

Langmuir : the ACS journal of surfaces and colloids

Fujii S, Miyake R, Campo L, Lee JH, Takahashi R, Sakurai K.
PMID: 32391699
Langmuir. 2020 Jun 09;36(22):6222-6227. doi: 10.1021/acs.langmuir.0c00861. Epub 2020 May 19.

In 1997, a study based on X-ray crystallography revealed that resorcinarenes adopt a hexameric capsule-like structure. The function of resorcinarenes has been discussed on the basis of this structure; however, our recent study showed that the hexamer may be...

Cite
Fujii S, Miyake R, Campo L, et al. Structural Polymorphism of Resorcinarene Assemblies. Langmuir. 2020;36(22):6222-6227doi: 10.1021/acs.langmuir.0c00861.
Fujii, S., Miyake, R., Campo, L., Lee, J. H., Takahashi, R., & Sakurai, K. (2020). Structural Polymorphism of Resorcinarene Assemblies. Langmuir : the ACS journal of surfaces and colloids, 36(22), 6222-6227. https://doi.org/10.1021/acs.langmuir.0c00861
Fujii, Shota, et al. "Structural Polymorphism of Resorcinarene Assemblies." Langmuir : the ACS journal of surfaces and colloids vol. 36,22 (2020): 6222-6227. doi: https://doi.org/10.1021/acs.langmuir.0c00861
Fujii S, Miyake R, Campo L, Lee JH, Takahashi R, Sakurai K. Structural Polymorphism of Resorcinarene Assemblies. Langmuir. 2020 Jun 09;36(22):6222-6227. doi: 10.1021/acs.langmuir.0c00861. Epub 2020 May 19. PMID: 32391699.
Copy Download .nbib Format: NLM
Characterisation of an enhanced preclinical model of experimental MPO-ANCA autoimmune vasculitis.

The Journal of pathology

Prendecki M, Gulati K, Turner-Stokes T, Bhangal G, Chiappo D, Woollard K, Cook HT, Tam FW, Roufosse C, Pusey CD, McAdoo SP.
PMID: 34124781
J Pathol. 2021 Oct;255(2):107-119. doi: 10.1002/path.5746. Epub 2021 Jul 23.

Experimental autoimmune vasculitis (EAV) is a model of antineutrophil cytoplasm antibody (ANCA)-associated vasculitis (AAV) induced by immunisation of susceptible rat strains with myeloperoxidase (MPO). Animals develop circulating MPO-ANCA, pulmonary haemorrhage, and glomerulonephritis, although renal injury is mild and recovers...

Cite
Prendecki M, Gulati K, Turner-Stokes T, et al. Characterisation of an enhanced preclinical model of experimental MPO-ANCA autoimmune vasculitis. J Pathol. 2021;255(2):107-119doi: 10.1002/path.5746.
Prendecki, M., Gulati, K., Turner-Stokes, T., Bhangal, G., Chiappo, D., Woollard, K., Cook, H. T., Tam, F. W., Roufosse, C., Pusey, C. D., & McAdoo, S. P. (2021). Characterisation of an enhanced preclinical model of experimental MPO-ANCA autoimmune vasculitis. The Journal of pathology, 255(2), 107-119. https://doi.org/10.1002/path.5746
Prendecki, Maria, et al. "Characterisation of an enhanced preclinical model of experimental MPO-ANCA autoimmune vasculitis." The Journal of pathology vol. 255,2 (2021): 107-119. doi: https://doi.org/10.1002/path.5746
Prendecki M, Gulati K, Turner-Stokes T, Bhangal G, Chiappo D, Woollard K, Cook HT, Tam FW, Roufosse C, Pusey CD, McAdoo SP. Characterisation of an enhanced preclinical model of experimental MPO-ANCA autoimmune vasculitis. J Pathol. 2021 Oct;255(2):107-119. doi: 10.1002/path.5746. Epub 2021 Jul 23. PMID: 34124781.
Copy Download .nbib Format: NLM
The first reported case of trastuzumab induced interstitial lung disease associated with anti-neutrophil cytoplasmic antibody vasculitis - A case report and a prospective cohort study on the usefulness of neutrophil derived biomarkers in monitoring vasculitis disease activity during follow-up.

Breast (Edinburgh, Scotland)

Chang CH, Jung CJ, Huang YM, Chiao L, Chang YL, Hsieh SC, Lin CH, Kuo YM.
PMID: 34894465
Breast. 2021 Nov 29;61:35-42. doi: 10.1016/j.breast.2021.11.016. Epub 2021 Nov 29.

Targeted therapies against human epidermal growth factor receptor 2 (HER2) are associated with increased interstitial lung disease (ILD). Trastuzumab, lapatinib, pertuzumab, and trastuzumab emtansine have markedly extended HER2 breast cancer survival but current knowledge on how these HER2-targeted agents...

Cite
Chang CH, Jung CJ, Huang YM, et al. The first reported case of trastuzumab induced interstitial lung disease associated with anti-neutrophil cytoplasmic antibody vasculitis - A case report and a prospective cohort study on the usefulness of neutrophil derived biomarkers in monitoring vasculitis disease activity during follow-up. Breast. 2021;61:35-42doi: 10.1016/j.breast.2021.11.016.
Chang, C. H., Jung, C. J., Huang, Y. M., Chiao, L., Chang, Y. L., Hsieh, S. C., Lin, C. H., & Kuo, Y. M. (2021). The first reported case of trastuzumab induced interstitial lung disease associated with anti-neutrophil cytoplasmic antibody vasculitis - A case report and a prospective cohort study on the usefulness of neutrophil derived biomarkers in monitoring vasculitis disease activity during follow-up. Breast (Edinburgh, Scotland), 6135-42. https://doi.org/10.1016/j.breast.2021.11.016
Chang, Chen-Han, et al. "The first reported case of trastuzumab induced interstitial lung disease associated with anti-neutrophil cytoplasmic antibody vasculitis - A case report and a prospective cohort study on the usefulness of neutrophil derived biomarkers in monitoring vasculitis disease activity during follow-up." Breast (Edinburgh, Scotland) vol. 61 (2021): 35-42. doi: https://doi.org/10.1016/j.breast.2021.11.016
Chang CH, Jung CJ, Huang YM, Chiao L, Chang YL, Hsieh SC, Lin CH, Kuo YM. The first reported case of trastuzumab induced interstitial lung disease associated with anti-neutrophil cytoplasmic antibody vasculitis - A case report and a prospective cohort study on the usefulness of neutrophil derived biomarkers in monitoring vasculitis disease activity during follow-up. Breast. 2021 Nov 29;61:35-42. doi: 10.1016/j.breast.2021.11.016. Epub 2021 Nov 29. PMID: 34894465; PMCID: PMC8669110.
Copy Download .nbib Format: NLM
The first reported case of trastuzumab induced interstitial lung disease associated with anti-neutrophil cytoplasmic antibody vasculitis - A case report and a prospective cohort study on the usefulness of neutrophil derived biomarkers in monitoring vasculitis disease activity during follow-up.

Breast (Edinburgh, Scotland)

Chang CH, Jung CJ, Huang YM, Chiao L, Chang YL, Hsieh SC, Lin CH, Kuo YM.
PMID: 34894465
Breast. 2021 Nov 29;61:35-42. doi: 10.1016/j.breast.2021.11.016. Epub 2021 Nov 29.

Targeted therapies against human epidermal growth factor receptor 2 (HER2) are associated with increased interstitial lung disease (ILD). Trastuzumab, lapatinib, pertuzumab, and trastuzumab emtansine have markedly extended HER2 breast cancer survival but current knowledge on how these HER2-targeted agents...

Cite
Chang CH, Jung CJ, Huang YM, et al. The first reported case of trastuzumab induced interstitial lung disease associated with anti-neutrophil cytoplasmic antibody vasculitis - A case report and a prospective cohort study on the usefulness of neutrophil derived biomarkers in monitoring vasculitis disease activity during follow-up. Breast. 2021;61:35-42doi: 10.1016/j.breast.2021.11.016.
Chang, C. H., Jung, C. J., Huang, Y. M., Chiao, L., Chang, Y. L., Hsieh, S. C., Lin, C. H., & Kuo, Y. M. (2021). The first reported case of trastuzumab induced interstitial lung disease associated with anti-neutrophil cytoplasmic antibody vasculitis - A case report and a prospective cohort study on the usefulness of neutrophil derived biomarkers in monitoring vasculitis disease activity during follow-up. Breast (Edinburgh, Scotland), 6135-42. https://doi.org/10.1016/j.breast.2021.11.016
Chang, Chen-Han, et al. "The first reported case of trastuzumab induced interstitial lung disease associated with anti-neutrophil cytoplasmic antibody vasculitis - A case report and a prospective cohort study on the usefulness of neutrophil derived biomarkers in monitoring vasculitis disease activity during follow-up." Breast (Edinburgh, Scotland) vol. 61 (2021): 35-42. doi: https://doi.org/10.1016/j.breast.2021.11.016
Chang CH, Jung CJ, Huang YM, Chiao L, Chang YL, Hsieh SC, Lin CH, Kuo YM. The first reported case of trastuzumab induced interstitial lung disease associated with anti-neutrophil cytoplasmic antibody vasculitis - A case report and a prospective cohort study on the usefulness of neutrophil derived biomarkers in monitoring vasculitis disease activity during follow-up. Breast. 2021 Nov 29;61:35-42. doi: 10.1016/j.breast.2021.11.016. Epub 2021 Nov 29. PMID: 34894465; PMCID: PMC8669110.
Copy Download .nbib Format: NLM
The first reported case of trastuzumab induced interstitial lung disease associated with anti-neutrophil cytoplasmic antibody vasculitis - A case report and a prospective cohort study on the usefulness of neutrophil derived biomarkers in monitoring vasculitis disease activity during follow-up.

Breast (Edinburgh, Scotland)

Chang CH, Jung CJ, Huang YM, Chiao L, Chang YL, Hsieh SC, Lin CH, Kuo YM.
PMID: 34894465
Breast. 2021 Nov 29;61:35-42. doi: 10.1016/j.breast.2021.11.016. Epub 2021 Nov 29.

Targeted therapies against human epidermal growth factor receptor 2 (HER2) are associated with increased interstitial lung disease (ILD). Trastuzumab, lapatinib, pertuzumab, and trastuzumab emtansine have markedly extended HER2 breast cancer survival but current knowledge on how these HER2-targeted agents...

Cite
Chang CH, Jung CJ, Huang YM, et al. The first reported case of trastuzumab induced interstitial lung disease associated with anti-neutrophil cytoplasmic antibody vasculitis - A case report and a prospective cohort study on the usefulness of neutrophil derived biomarkers in monitoring vasculitis disease activity during follow-up. Breast. 2021;61:35-42doi: 10.1016/j.breast.2021.11.016.
Chang, C. H., Jung, C. J., Huang, Y. M., Chiao, L., Chang, Y. L., Hsieh, S. C., Lin, C. H., & Kuo, Y. M. (2021). The first reported case of trastuzumab induced interstitial lung disease associated with anti-neutrophil cytoplasmic antibody vasculitis - A case report and a prospective cohort study on the usefulness of neutrophil derived biomarkers in monitoring vasculitis disease activity during follow-up. Breast (Edinburgh, Scotland), 6135-42. https://doi.org/10.1016/j.breast.2021.11.016
Chang, Chen-Han, et al. "The first reported case of trastuzumab induced interstitial lung disease associated with anti-neutrophil cytoplasmic antibody vasculitis - A case report and a prospective cohort study on the usefulness of neutrophil derived biomarkers in monitoring vasculitis disease activity during follow-up." Breast (Edinburgh, Scotland) vol. 61 (2021): 35-42. doi: https://doi.org/10.1016/j.breast.2021.11.016
Chang CH, Jung CJ, Huang YM, Chiao L, Chang YL, Hsieh SC, Lin CH, Kuo YM. The first reported case of trastuzumab induced interstitial lung disease associated with anti-neutrophil cytoplasmic antibody vasculitis - A case report and a prospective cohort study on the usefulness of neutrophil derived biomarkers in monitoring vasculitis disease activity during follow-up. Breast. 2021 Nov 29;61:35-42. doi: 10.1016/j.breast.2021.11.016. Epub 2021 Nov 29. PMID: 34894465; PMCID: PMC8669110.
Copy Download .nbib Format: NLM
Gradient coil and radiofrequency induced heating of orthopaedic implants in MRI: influencing factors.

Physics in medicine and biology

Wooldridge J, Arduino A, Zilberti L, Zanovello U, Chiampi M, Clementi V, Bottauscio O.
PMID: 34847533
Phys Med Biol. 2021 Nov 30; doi: 10.1088/1361-6560/ac3eab. Epub 2021 Nov 30.

Patients with implanted orthopaedic devices represent a growing number of subjects undergoing magnetic resonance imaging (MRI) scans each year. MRI safety labelling is required for all implants under the EU Medical Device Regulations to ensure regulatory compliance, with each...

Cite
Wooldridge J, Arduino A, Zilberti L, et al. Gradient coil and radiofrequency induced heating of orthopaedic implants in MRI: influencing factors. Phys Med Biol. 2021;doi: 10.1088/1361-6560/ac3eab.
Wooldridge, J., Arduino, A., Zilberti, L., Zanovello, U., Chiampi, M., Clementi, V., & Bottauscio, O. (2021). Gradient coil and radiofrequency induced heating of orthopaedic implants in MRI: influencing factors. Physics in medicine and biology, . https://doi.org/10.1088/1361-6560/ac3eab
Wooldridge, Jenny, et al. "Gradient coil and radiofrequency induced heating of orthopaedic implants in MRI: influencing factors." Physics in medicine and biology vol. (2021). doi: https://doi.org/10.1088/1361-6560/ac3eab
Wooldridge J, Arduino A, Zilberti L, Zanovello U, Chiampi M, Clementi V, Bottauscio O. Gradient coil and radiofrequency induced heating of orthopaedic implants in MRI: influencing factors. Phys Med Biol. 2021 Nov 30; doi: 10.1088/1361-6560/ac3eab. Epub 2021 Nov 30. PMID: 34847533.
Copy Download .nbib Format: NLM
The underestimated role of gradient coils in MRI safety.

Magnetic resonance in medicine

Zilberti L, Arduino A, Bottauscio O, Chiampi M.
PMID: 27851880
Magn Reson Med. 2017 Jan;77(1):13-15. doi: 10.1002/mrm.26544. Epub 2016 Nov 07.

No abstract available.

Cite
Zilberti L, Arduino A, Bottauscio O, et al. The underestimated role of gradient coils in MRI safety. Magn Reson Med. 2016;77(1):13-15doi: 10.1002/mrm.26544.
Zilberti, L., Arduino, A., Bottauscio, O., & Chiampi, M. (2017). The underestimated role of gradient coils in MRI safety. Magnetic resonance in medicine, 77(1), 13-15. https://doi.org/10.1002/mrm.26544
Zilberti, Luca, et al. "The underestimated role of gradient coils in MRI safety." Magnetic resonance in medicine vol. 77,1 (2017): 13-15. doi: https://doi.org/10.1002/mrm.26544
Zilberti L, Arduino A, Bottauscio O, Chiampi M. The underestimated role of gradient coils in MRI safety. Magn Reson Med. 2017 Jan;77(1):13-15. doi: 10.1002/mrm.26544. Epub 2016 Nov 07. PMID: 27851880.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 70 entries